Why Kura Oncology shares tumbled after securing a $1.2bn cancer-drug partnership

Kura Oncology, Inc., a clinical-stage biopharmaceutical innovator, and Japan-based pharmaceutical leader Kyowa Kirin Co., Ltd., have entered into a strategic partnership that could redefine treatment ... Read More